Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

The Harvard Drug Group LLC recalls Memantine Hydrochloride Extended-Release

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Failed Dissolution Specifications
Products
  • Memantine Hydrochloride Extended-Release
Where it was sold

US Nationwide.

Nationwide

Units affected
N/A
About this recall
Memantine Hydrochloride Extended-Release, Capsules, 7 mg, 100 Capsules (10 x 10 blister packs), Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268, NDC 0904-6734-61